These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 207416

  • 41. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
    Sato A, Montgomery JA, Cory JG.
    Cancer Res; 1984 Aug; 44(8):3286-90. PubMed ID: 6611198
    [Abstract] [Full Text] [Related]

  • 42. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T, Manouilov KK, Shanmuganathan K, Kotra LP, Boudinot FD, Cretton-Scott E, Sommadossi JP, Schinazi RF, Chu CK.
    J Med Chem; 1996 Nov 08; 39(23):4676-81. PubMed ID: 8917656
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of equine S-adenohomocysteine hydrolase by 2'-deoxyadenosine.
    Magnuson NS, Perryman LE, Decker DM, Magnuson JA.
    Int J Biochem; 1984 Nov 08; 16(11):1163-5. PubMed ID: 6335439
    [Abstract] [Full Text] [Related]

  • 44. Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
    Sidwell RW, Allen LB, Huffman JH, Revankar GR, Robins RK, Tolman RL.
    Antimicrob Agents Chemother; 1975 Oct 08; 8(4):463-7. PubMed ID: 1190753
    [Abstract] [Full Text] [Related]

  • 45. Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
    Kuroki Y, Shimoyama M, Inaba S, Hirose M.
    Jpn J Cancer Res; 1989 May 08; 80(5):482-9. PubMed ID: 2502523
    [Abstract] [Full Text] [Related]

  • 46. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.
    Bryson Y, Connor JD, Sweetman L, Carey S, Stuckey MA, Buchanan R.
    Antimicrob Agents Chemother; 1974 Jul 08; 6(1):98-101. PubMed ID: 15828177
    [Abstract] [Full Text] [Related]

  • 47. Influence of coformycin on the cytostatic activity of 9-beta-D-arabinofuranosyladenine and adenosine in mouse L5178y cells.
    Müller WE, Zahn RK, Arendes J, Maidhof A, Umezawa H.
    Hoppe Seylers Z Physiol Chem; 1978 Oct 08; 359(10):1287-95. PubMed ID: 309844
    [No Abstract] [Full Text] [Related]

  • 48. Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
    O'Brien WJ.
    Curr Eye Res; 1986 Aug 08; 5(8):595-9. PubMed ID: 3489583
    [Abstract] [Full Text] [Related]

  • 49. Antagonism of the cytotoxic but not antiviral effects of ara-sangivamycin by adenosine.
    Birch GM, Krawczyk SH, Townsend LB, Drach JC.
    Antimicrob Agents Chemother; 1989 Sep 08; 33(9):1606-8. PubMed ID: 2554803
    [Abstract] [Full Text] [Related]

  • 50. Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.
    Connor JD, Sweetman L, Carey S, Stuckey MA, Buchanan R.
    Antimicrob Agents Chemother; 1974 Nov 08; 6(5):630-6. PubMed ID: 15825318
    [Abstract] [Full Text] [Related]

  • 51. Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.
    Hidaka T, Katayama K, Yamashita K, Yamashita T, Watanabe K, Shimazaki M, Ohno M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1980 Mar 08; 33(3):303-9. PubMed ID: 7380742
    [Abstract] [Full Text] [Related]

  • 52. Selective Growth Inhibition of Sphaerotilus natans and Beggiatoa sp. by Nucleosides.
    Takiguchi Y, Yoshikawa H, Terao M.
    Appl Environ Microbiol; 1978 Nov 08; 36(5):658-61. PubMed ID: 16345327
    [Abstract] [Full Text] [Related]

  • 53. Inhibition of experimental deoxyribonucleic acid virus-induced encephalitis by 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
    Allen LB, Thompson JM, Huffman JH, Revankar GR, Tolman RL, Simon LN, Robins RK, Sidwell RW.
    Antimicrob Agents Chemother; 1975 Oct 08; 8(4):468-73. PubMed ID: 172008
    [Abstract] [Full Text] [Related]

  • 54. Antiproliferative effects of 9-beta-d-arabinofuranosyladenine in a mammalian cell line devoid of adenosine deaminase activity.
    Drach JC, Sandberg JN, Shipman C.
    J Dent Res; 1977 Mar 08; 56(3):275-88. PubMed ID: 192768
    [Abstract] [Full Text] [Related]

  • 55. Inhibition of adenosine deaminase by azapurine ribonucleosides.
    Shewach DS, Krawczyk SH, Acevedo OL, Townsend LB.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1697-700. PubMed ID: 1449528
    [Abstract] [Full Text] [Related]

  • 56. Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate.
    Ayisi NK, Meldrum JB, Stuart AL, Gupta VS.
    Antiviral Res; 1983 Sep 03; 3(3):161-74. PubMed ID: 6197027
    [Abstract] [Full Text] [Related]

  • 57. Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.
    Shannon WM.
    Ann N Y Acad Sci; 1977 Mar 04; 284():472-507. PubMed ID: 280146
    [Abstract] [Full Text] [Related]

  • 58. Inhibition of vesicular stomatitis virus replication by 9-beta-D-arabinofuranosyladenine.
    Grant JA, Sabina LR.
    Antimicrob Agents Chemother; 1972 Sep 04; 2(3):201-5. PubMed ID: 4364172
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.